Milling Operations: Tempering process control
Taking adequate measures to reflect the nature of the process
Source: world-grain.com
Page 38 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Confidence Interval Today - Breaking & Trending Today
NaV1.8 inhibitor VX-548 reduces acute post-operative pain
1. In this randomized controlled trial, the elective NaV1.8 inhibitor VX-548 reduced acute pain over 48 hours following abdominoplasty and bunionectomy. 2. The main adverse events associated with VX-548 use were headaches and constipation. Evidence Rating Level: 1 (Excellent) Study Rundown: Acute pain, especially following traumas and surgical procedures, remains an area of unmet medical
Source: 2minutemedicine.com
Lorundrostat Shows Promise in Phase 2 Trial for Uncontrolled, Resistant Hypertension
New data from a dose-finding trial suggests the aldosterone synthase inhibitor lorundrostat could find a role in the management of resistant or uncontrolled hypertension.
Source: hcplive.com
#VisualAbstract: Low-dose glucocorticoids for rheumatoid arthritis do not increase blood pressure
1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids taken over a two-year period did not increase patient blood pressure. 2. Low-dose glucocorticoid use was associated with an increase in weight of one kilogram on average. Evidence Rating Level: 1 (Excellent) Study Rundown: Glucocorticoids are commonly used in the management of rheumatoid arthritis (RA), though
Source: 2minutemedicine.com
HUTCHMED Highlights Presentation of Results from the Phase
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM, HKEX: 13) today...
Source: globenewswire.com